Christine Posted October 30, 2007 Share Posted October 30, 2007 http://www.reuters.com/article/inPlayBr ... EL20071030 Co announces that Intae Lee with the University of Pennsylvania has reported that Alfacell's Onconase could be a promising radiation sensitizer for lung cancer treatment. Lee presented the pre-clinical in vivo data at the American Society for Therapeutic Radiology and Oncology 49th Annual Meeting. Lee provided pre-clinical evidence that Onconase significantly increased the radiation-induced tumor growth delay of lung tumors in vivo without increases in skin reaction compared to radiation alone. Additionally, Lee and his team of researchers identified non-invasive imaging biomarkers that can potentially be used as a therapeutic predictor for Onconase in non-small cell lung cancer patients. "Onconase significantly reduced the tumor hypertension that is the major physiological barrier of therapeutic delivery to solid tumors," said Lee. "As a result, Onconase increased tumor penetration and selectively increased tumor blood flow. This investigation suggests that Onconase may be a new and promising drug in the treatment of non-small cell lung carcinoma patients as a radiation therapy enhancer." Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.